This is intended for HCPs practising in Great Britain (England, Scotland, Wales) only.
Prescribing Information for SARCLISA® (isatuximab) can be found via the Product Card at the bottom of the page.

Supporting your Patients

Articles and materials to support your patient’s needs


Relapsed Refractory Multiple Myeloma Product

Click here for product and therapy information and related patient case study videos.


MAT-XU-2203826 (v1.0)
Date of preparation: September 2023

This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.